000 01015 a2200253 4500
005 20250516013218.0
264 0 _c20110503
008 201105s 0 0 eng d
022 _a1464-3391
024 7 _a10.1016/j.bmc.2010.10.057
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhadka, Daulat Bikram
245 0 0 _a3-Arylisoquinolines as novel topoisomerase I inhibitors.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry
_cJan 2011
300 _a724-34 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aDNA Topoisomerases, Type I
_xchemistry
650 0 4 _aIsoquinolines
_xchemical synthesis
650 0 4 _aTopoisomerase I Inhibitors
_xchemical synthesis
700 1 _aCho, Won-Jea
773 0 _tBioorganic & medicinal chemistry
_gvol. 19
_gno. 2
_gp. 724-34
856 4 0 _uhttps://doi.org/10.1016/j.bmc.2010.10.057
_zAvailable from publisher's website
999 _c20391304
_d20391304